GLP-1 drugs found to lower cancer risk in diabetes patients

[News]

Research finds that GLP-1 receptor agonists significantly reduce the risk of 10 out of 13 obesity-associated cancers in type 2 diabetes patients compared to insulins, but show varied results against metformin.

More... (https://www.news-medical.net/news/20240708/GLP-1-drugs-found-to-lower-cancer-risk-in-diabetes-patients.aspx)